CYP19A1 and breast carcinoma: Selective oestrogen receptor modulators (SERMs), such as lasofoxifene, raloxifene, and tamoxifen, and aromatase inhibitors, i.e. anastrozole, letrozole, and exemestane, are drugs applied in breast cancer therapy.